Affected Alaris products may have been serviced with previously recalled bezel kit assemblies. BD in 2019 recalled those kit ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people.

Discover the four key trends and innovations driving infusion therapy for chronic diseases as we head into 2025. Stay informed and up-to-date on the latest advancements in healthcare.

AbbVie has launched its Produodopa for Parkinson’s in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the disease.

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software, and ...